Smoking Patients
Conditions
Brief summary
Tobacco consumption is a major public health problem, ranking second in the leading cause of morbidity and mortality worldwide, in 2010. The prevalence of tobacco smoking in hospitalized patients is evaluated around 20% and the management of tobacco reduction/cessation is an major issue for the course and outcome of many disorders. Recent recommendations published by the French National Health Authority (Haute Autorité de Santé, HAS) call for the involvement of all health professionals in helping patients to stop smoking and hospitalized patients are identified as a specific target. In addition, the meta-analysis of Rigotti et al. (2012) showed that the most effective programs (tobacco cessation) were those that include all patients, starting during the hospitalization with a specific follow-up of at least one month, and with the addition of nicotine replacement therapy. This combination increased the odds of successful tobacco cessation by 54%. The project aims to evaluate the short-term efficacy (1 month) of a nurse-based program on tobacco smoking consumption in a population of hospitalized patients.
Interventions
OTHERTobacco management
Training of healthcare teams for tobacco management by trained nurses. The intervention will consist of 3 minimum interviews, about 30 minutes each.
Sponsors
Assistance Publique - Hôpitaux de Paris
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patient (\>= 18 years), tobacco smokers, hospitalized in one of the participating unit during the inclusion period. * For the sake of coherence with the literature, only subjects who smoked at least one cigarette a day in the previous 30 days before the hospitalization will be considered as smokers. * Affiliated to the national health system * Signed informed consent
Exclusion criteria
* Patients enrolled in an addiction treatment during their hospitalization stay * Cognitive deficit that makes the informed consent and the telephone interview impossible * Aphasia * Patient who does not speak French * Life expectancy below 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 month tobacco smoking prevalence | 1 month |
Secondary
| Measure | Time frame |
|---|---|
| 6 month tobacco smoking prevalence | 6 months |
Countries
France
Outcome results
None listed